Overview

C1-inhibitor in Allergic ASThma Patients

Status:
Terminated
Trial end date:
2019-10-23
Target enrollment:
Participant gender:
Summary
The purpose of this proof-of-concept study is to determine the effect of Intestinal Microbiota Depletion or Intravenous Administration of C1-inhibitor on Inflammation and Coagulation after Bronchial Instillation of House Dust Mite Allergen and Lipopolysaccharide in Allergic Asthma Patients
Phase:
Phase 4
Details
Lead Sponsor:
T. van der Poll
Collaborators:
Sanquin
Sanquin Plasma Products BV
ZonMw: The Netherlands Organisation for Health Research and Development
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Ciprofloxacin
Complement C1 Inactivator Proteins
Metronidazole
Vancomycin